A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors
Titel:
A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors
Auteur:
Kieran, Mark W. Chi, Susan Goldman, Stewart Onar-Thomas, Arzu Poussaint, Tina Young Vajapeyam, Sridhar Fahey, Frederic Wu, Shengjie Turner, David C. Stewart, Clinton F. Moses, Marsha Packer, Roger J. Jakacki, Regina Banerjee, Anu Boyett, James M. Fouladi, Maryam Kun, Larry